(Harbinger’s Daily)—Pressure is growing on federal agencies to regulate the abortion drug mifepristone, following publication of a series of alarming reports. The latest report, published last week by the Charlotte Lozier Institute (CLI), analyzed Medicare and Medicaid data and discovered that the vast majority (over 80%) of women who visited an emergency room with complications from the abortion drug had their abortions miscoded as miscarriages.
The study examined nearly 30,000 emergency room visits and found that between 2016 and 2021, a period of five years, miscodes of emergency room visits following surgical abortions increased in prevalence from a rate of 26.8% to 73.9%, while miscodes of ER visits following mifepristone abortions increased in prevalence from a rate of 45.5% to 83.5%. Additionally, acuity — that is, the measure of the severity and complexity of a patient’s condition — was significantly higher (at a rate of 50%) among miscoded cases than correctly-coded cases.
“When abortion-related emergencies are disguised as miscarriages, it impairs a doctor’s ability to make informed, evidence-based decisions. That isn’t just a documentation error — it’s a public health crisis,” said Dr. James Studnicki, vice president and director of data analytics at CLI and one of the authors of the study, in a statement obtained by The Washington Stand. He added, “The abortion industry’s push for concealment is unethical and dangerous. Women deserve honest guidance and proper medical care, not advice that jeopardizes their health.”
Another of the study’s authors, CLI Vice President and Director of Medical Affairs Dr. Ingrid Skop, told TWS, “As a board-certified OB-GYN practicing in Texas, I’ve seen firsthand the devastating effects abortion drugs have on women, as I have been called to care for them in the ER regularly.” She explained, “This study exposes the abortion industry’s reckless advice for women to hide their abortion drug use from doctors, delaying proper care and risking their health.”
- Read More: harbingersdaily.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.